Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 3307044 | HLA-DR (HLA-DR) | transplantation | NA | NA | NA | unclassified | |
| a pretransplant (n = 14) and serial transplant biopsies (n = 45) were obtained from 14 transplant recipients in whom induced hla-class ii antigen was detected after transplantation with a monoclonal antibody reactive with hla-dr, dp, and possibly dq antigens. | |||||||
| 3307044 | NA (NA) | transplantation | NA | NA | NA | unclassified | |
| after transplantation grafts with induced tubular hla-class ii antigen had induced hla-dr, dq and dp antigens expressed both within the cytoplasm and on the cell membranes. | |||||||
| 3307044 | DP (HAPLOTYPE) | transplantation | NA | NA | NA | unclassified | |
| after transplantation grafts with induced tubular hla-class ii antigen had induced hla-dr, dq and dp antigens expressed both within the cytoplasm and on the cell membranes. | |||||||
| 3307044 | HLA-DR (HLA-DR) | transplantation | NA | NA | NA | unclassified | |
| after transplantation grafts with induced tubular hla-class ii antigen had induced hla-dr, dq and dp antigens expressed both within the cytoplasm and on the cell membranes. | |||||||
| 3307044 | HLA (HLA) | transplantation | NA | NA | NA | positive | |
| this approach demonstrated that the induced class ii antigen is of donor origin--and, furthermore, that the renal parenchyma remains of donor hla-type, even one year after transplantation, and thus remains a source of antigenic stimulus to the recipient. | |||||||
| 3307408 | HLA IDENTICAL (HLA-IDENTICAL) | transplantation | NA | NA | NA | unclassified | |
| the results of high-dose chemoradiotherapy and marrow transplantation from an hla-identical sibling for various stages and types of leukemia and lymphoma are summarized. | |||||||
| 3307408 | HLA IDENTICAL (HLA-IDENTICAL) | leukemia | NA | NA | NA | unclassified | |
| the results of high-dose chemoradiotherapy and marrow transplantation from an hla-identical sibling for various stages and types of leukemia and lymphoma are summarized. | |||||||
| 3307408 | HLA IDENTICAL (HLA-IDENTICAL) | lymphoma | NA | NA | NA | unclassified | |
| the results of high-dose chemoradiotherapy and marrow transplantation from an hla-identical sibling for various stages and types of leukemia and lymphoma are summarized. | |||||||
| 3310793 | HLA (HLA) | transplantation | NA | methotrexate | NA | unclassified | |
| factors associated with a lower year-1 fev1/fvc (%) included increased age (p less than 0.0001), male gender (p = 0.02), cigarette smoking (p = 0.01), lower fev1/fvc before transplantation (p less than 0.0001), hla-nonidentical grafts (p = 0.001), chronic graft-versus-host disease (p = 0.0002), and immunosuppressive therapy with methotrexate (p = 0.01). | |||||||
| 3310793 | HLA (HLA) | graft-versus-host disease | NA | methotrexate | NA | unclassified | |
| factors associated with a lower year-1 fev1/fvc (%) included increased age (p less than 0.0001), male gender (p = 0.02), cigarette smoking (p = 0.01), lower fev1/fvc before transplantation (p less than 0.0001), hla-nonidentical grafts (p = 0.001), chronic graft-versus-host disease (p = 0.0002), and immunosuppressive therapy with methotrexate (p = 0.01). | |||||||
Copyright 2024